Preetam Shah - Chief Strategy and Financial Officer at Elicio Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Strategy and Financial Officer
Issuer Symbol
ELTX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Preetam Shah since 25 Feb 2025

Holdings reported by Preetam Shah for Elicio Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 24,000 $191,040 $7.96 02 Feb 2026 Direct
Stock Option (Right to Buy) 47,900 02 Feb 2026 Direct Common Stock

Transactions reported by Preetam Shah for Elicio Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.